- Home
- PLUR vs RBOT Comparison
PLUR vs RBOT Comparison
Compare PLUR & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUR
- RBOT
- Stock Information
- Founded
- PLUR 2001
- RBOT 2014
- Country
- PLUR Israel
- RBOT United States
- Employees
- PLUR N/A
- RBOT N/A
- Industry
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- RBOT Medical Specialities
- Sector
- PLUR Health Care
- RBOT Health Care
- Exchange
- PLUR Nasdaq
- RBOT Nasdaq
- Market Cap
- PLUR 36.9M
- RBOT 38.3M
- IPO Year
- PLUR N/A
- RBOT N/A
- Fundamental
- Price
- PLUR $3.91
- RBOT $5.35
- Analyst Decision
- PLUR Strong Buy
- RBOT Hold
- Analyst Count
- PLUR 1
- RBOT 1
- Target Price
- PLUR $12.00
- RBOT $7.00
- AVG Volume (30 Days)
- PLUR 10.5K
- RBOT 133.3K
- Earning Date
- PLUR 11-11-2025
- RBOT 11-10-2025
- Dividend Yield
- PLUR N/A
- RBOT N/A
- EPS Growth
- PLUR N/A
- RBOT N/A
- EPS
- PLUR N/A
- RBOT N/A
- Revenue
- PLUR $1,336,000.00
- RBOT N/A
- Revenue This Year
- PLUR $97.38
- RBOT N/A
- Revenue Next Year
- PLUR $293.97
- RBOT N/A
- P/E Ratio
- PLUR N/A
- RBOT N/A
- Revenue Growth
- PLUR 309.82
- RBOT N/A
- 52 Week Low
- PLUR $3.33
- RBOT $5.00
- 52 Week High
- PLUR $7.13
- RBOT $19.00
- Technical
- Relative Strength Index (RSI)
- PLUR 41.69
- RBOT 40.87
- Support Level
- PLUR $3.60
- RBOT $5.60
- Resistance Level
- PLUR $4.09
- RBOT $6.19
- Average True Range (ATR)
- PLUR 0.18
- RBOT 0.48
- MACD
- PLUR -0.02
- RBOT -0.05
- Stochastic Oscillator
- PLUR 30.69
- RBOT 0.00
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.